Moderna secures FDA EUA for its Covid-19 Vaccine mRNA-1273
The company intends to deliver around 20 million doses to the US government by the end of December…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Dec 20
The company intends to deliver around 20 million doses to the US government by the end of December…
18 Dec 20
The FDA approval is based on the positive results of the BLISS-LN study, and the prevalent unmet medical…
18 Dec 20
Riabni is a cytolytic antibody that works similar to Rituxan, with no clinically meaningful differences in safety or…
17 Dec 20
The Swiss pharmaceutical firm also secured Rare Pediatric Disease Designation for the treatment of C3 glomerulopathy (C3G)
15 Dec 20
The US FDA approval is based on data from the ENSEMBLE PLUS study, in which two-hour Ocrevus infusion…
14 Dec 20
Leqvio claimed to be the first and only approved small-interfering RNA (siRNA) low-density lipoprotein cholesterol (LDL-C) lowering treatment…
10 Dec 20
Health Canada authorisation is based on Pfizer and BioNTech’s regulatory application, filed under the rolling submission regulatory pathway
04 Dec 20
Janssen’s BLA for amivantamab marks the first regulatory submission for the treatment of EGFR exon 20 insertion mutation-positive…
04 Dec 20
Orladeyo is the first once-daily oral therapy specifically designed to prevent attacks of HAE patients, by decreasing the…
03 Dec 20
The UK regulator MHRA has authorised the supply of mRNA-based Covid-19 vaccine for emergency use, with US FDA…